Latest Tissue plasminogen activator Stories
A naturally occurring substance shrank the size of stroke-induced lesions in the brains of experimental mice â€” even when administered as much as 12 hours after the event, Stanford University School of Medicine researchers have shown.
A citywide study published online in todayâ€™s issue of Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.
African-Americans are less likely than whites to receive critical stroke treatment primarily because they do not get to a hospital soon enough for time-sensitive treatment and because of preexisting medical conditions.
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 â€” but is still low.
A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective.
Strokes are not typically thought of as a childhood health issue, but Baylor College of Medicine experts warn that they do occur in children and can result in significant long-lasting effects.
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment.
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment, according to a study.
CENTENNIAL, Colo., May 2, 2011 /PRNewswire/ -- Bailey Carlson, 17, appears to live a typical teenage life. She is focused on school, friends and sleepovers.
Dr. George Rappardâ€™s Site is cleared to begin enrolling patients in new study. This clinical trial is the first U.S.
- A political dynamiter.